Explore clinical trials.
Take an informed next step.
Explore selected cell therapy studies, understand who may qualify, and find official study-team information.
These treatments are being studied. A trial listing does not mean a treatment is approved or suitable for you. Recruitment and eligibility must be confirmed with the study team.
SELECTED STUDIES06Official study records
LISTED AS RECRUITING03Confirm availability with study teams
CONDITION AREAS04Explore by condition
Find a clinical trial Selected studies
ClinicalTrials.gov
Showing 6 of 6 trials
Type 1 diabetesRecruiting
NCT04786262 • Phase 3
Islet cell replacement
Investigational use in this trial
Sponsor
Vertex Pharmaceuticals Incorporated
Key eligibility
18 Years – 65 Years · All Clinical history of T1D with \>=5 years of duration of insulin dependence At least two episodes of documented severe hypoglycemia in the 12 months prior to enrollment Stable diabetic treatment…
Locations
United States, Canada, France, Germany, Italy, Netherlands, Norway, Saudi Arabia, Switzerland, United Kingdom (29 sites)
Registry updated Sep 1, 2026 · Checked Nov 8, 2026
Parkinson’sRecruiting
NCT06944522 • Phase 3
Stem cell-derived neurons
Investigational use in this trial
Sponsor
BlueRock Therapeutics
Key eligibility
45 Years – 75 Years · All Diagnosis of clinically established PD as defined by the International Parkinson and Movement Disorders Society Individual of any sex ≥45 to ≤75 years of age at informed consent Robust and clear response to DA therapy as define…
Locations
United States, Australia, Canada (43 sites)
Registry updated Nov 2, 2026 · Checked Nov 8, 2026
Multiple sclerosisRecruiting
NCT04047628 • Phase 3
Autologous blood stem cell transplant
Investigational use in this trial
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Key eligibility
18 Years – 55 Years · All1. Age 18 to 55 years, inclusive, at the time of the screening Visit -2. 2. Diagnosis of MS according to the 2017 McDonald Criteria139. 3. EDSS ≤ 6.0 at the time of randomization (Day 0).…
Locations
United States (23 sites)
Registry updated Oct 20, 2026 · Checked Nov 8, 2026
Autoimmune diseasesCompleted
NCT02633163 • Phase 2
Mesenchymal stromal cells
Investigational use in this trial
Sponsor
Medical University of South Carolina
Key eligibility
18 Years – 65 Years · All Patients between 18 and 65 years old, male or female, of any race Historical presence of at least 4 of 11 of the ACR Classification Criteria Evidence of a positive ANA (≥1:80 titer) or positive dsDNA antibody test within 6 mont…
Locations
United States (9 sites)
Registry updated Aug 24, 2026 · Checked Nov 8, 2026
Parkinson’sCompleted
NCT04802733 • Phase 1
Stem cell-derived neurons
Investigational use in this trial
Sponsor
BlueRock Therapeutics
Key eligibility
50 Years – 78 Years · All Age 50-78 years old (Canada) Age 60-78 years old (United States) Diagnosis of Parkinson's Disease made between 3 to 20 years ago…
Locations
United States, Canada (3 sites)
Registry updated Nov 1, 2024 · Checked Nov 8, 2026
Autoimmune diseasesTerminated
NCT05938725 • Phase 1 / Phase 2
CAR T-cell therapy (not stem cells)
Investigational use in this trial
Sponsor
Kyverna Therapeutics
Key eligibility
18 Years – No maximum listed · All1. Age ≥18 years 2. Clinical diagnosis of SLE according to 2019 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria 3. Biopsy-proven proliferative LN Class III or IV according to…
Locations
United States (6 sites)
Registry updated Aug 31, 2026 · Checked Nov 8, 2026
KEEP THE CONTEXT
A trial is a question—not a promise.
Recruitment status does not mean a treatment is approved, effective, or right for an individual.
STAY INFORMED. STAY EMPOWERED.
Keep exploring with us.
Discover more science, perspectives, and conversations from Stem Cell Chronicles.
